Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Outcome measures for clinical trials in neuromuscular diseases are typically based on physical assessments which are dependent on patient effort, combine the effort of different muscle groups, and may not be sensitive to progression over short trial periods in slow-progressing diseases. We hypothesised that quantitative fat imaging by MRI (Dixon technique) could provide more discriminating quantitative, patient-independent measurements of the progress of muscle fat replacement within individual muscle groups. OBJECTIVE: To determine whether quantitative fat imaging could measure disease progression in a cohort of limb-girdle muscular dystrophy 2I (LGMD2I) patients over a 12 month period. METHODS: 32 adult patients (17 male;15 female) from 4 European tertiary referral centres with the homozygous c.826C>A mutation in the fukutin-related protein gene (FKRP) completed baseline and follow up measurements 12 months later. Quantitative fat imaging was performed and muscle fat fraction change was compared with (i) muscle strength and function assessed using standardized physical tests and (ii) standard T1-weighted MRI graded on a 6 point scale. RESULTS: There was a significant increase in muscle fat fraction in 9 of the 14 muscles analyzed using the quantitative MRI technique from baseline to 12 months follow up. Changes were not seen in the conventional longitudinal physical assessments or in qualitative scoring of the T₁w images. CONCLUSIONS: Quantitative muscle MRI, using the Dixon technique, could be used as an important longitudinal outcome measure to assess muscle pathology and monitor therapeutic efficacy in patients with LGMD2I.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
Podsiadlo, D., & Richardson, S. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb01616.x · Cited by 14,418 · cited 3×
“The timed tests for some individuals suggested an increase in time to perform the stair climb, stair descend, 10 m walk, chair rise, and TUG test.”
MethodATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Simple proton spectroscopic imaging.
Dixon, W. T. (1984) · Radiology · doi:10.1148/radiology.153.1.6089263 · Cited by 2,276 · cited 1×
“The quantitative Dixon technique allows fat fraction analysis [13], correcting for inhomogeneities in magnetic and radiofrequency fields which make signals on standard T1w images difficult to quantify (see Supporting Information in File S1 for more detail).”
MethodPrevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Three‐point dixon technique for true water/fat decomposition with B0 inhomogeneity correction
Glover, G. H., & Schneider, E. (1991) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910180211 · Cited by 687
Norwood, F. L. M., Harling, C., Chinnery, P. F., Eagle, M., Bushby, K., & Straub, V. (2009) · Brain · doi:10.1093/brain/awp236 · Cited by 541 · cited 2×
“Methods: 32 adult patients (17 male;15 female) from 4 European tertiary referral centres with the homozygous c.826C.A mutation in the fukutin-related protein gene (FKRP) completed baseline and follow up measurements 12 months later.”
BackgroundSelf-citationBrockington, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.25.2851 · Cited by 499 · cited 5×
“Future work could include both asymptomatic and paediatric patients with the common FKRP mutation, in order to further define the natural history of the disease.”
BackgroundInfluentialMuscle MRI in inherited neuromuscular disorders: Past, present, and future
Mercuri, E., Pichiecchio, A., Allsop, J., Messina, S., Pane, M., & Muntoni, F. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20804 · Cited by 439 · cited 1×
“Previous magnetic resonance imaging (MRI) research has concentrated on small cross-sectional studies employing standard T1-weighted imaging interpreted by radiological scoring and reporting the patterns of muscle involvement in specific muscular dystrophies [8,9,10,11,12].”
BackgroundReliability of the North Star Ambulatory Assessment in a multicentric setting
Mazzone, E. S., Messina, S., Vasco, G., Main, M., Eagle, M., D’Amico, A., Doglio, L., Politano, L., Cavallaro, F., Frosini, S., et al. (2009) · Neuromuscular Disorders · doi:10.1016/j.nmd.2009.06.368 · Cited by 231 · cited 1×
“Timed tests included a 10 metre walk/run [15], Timed Up and Go test (TUG) [16] and a six minute walk distance (6MWD) [17,18].”
MethodSelf-citationMercuri, E., Talim, B., Moghadaszadeh, B., Petit, N., Brockington, M., Counsell, S., Guicheney, P., Muntoni, F., & Merlini, L. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00023-8 · Cited by 215 · cited 1×
“[21,22] (Table 1), assessing 14 muscles in the leg (9 in the thigh and 5 in the lower leg) and the gluteus maximus muscle.”
BackgroundThe phenotype of limb-girdle muscular dystrophy type 2I
Poppe, M., Cree, L., Bourke, J., Eagle, M., Anderson, L. V. B., Birchall, D., Brockington, M., Buddles, M., Busby, M., Muntoni, F., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000058902.88181.3d · Cited by 195
Self-citationHand-held myometry: reference values.
van der Ploeg, R. J., Fidler, V, & Oosterhuis, H. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.3.244 · Cited by 185 · cited 1×
“Strength testing of the lower limb on the dominant side using a hand-held myometer (MicroFET) [14] included knee extension, knee flexion, hip abduction and hip adduction.”
MethodBushby, K. M. D. (1995) · Neuromuscular Disorders · doi:10.1016/0960-8966(93)e0006-g · Cited by 150
Self-citationTwo‐point Dixon technique for water‐fat signal decomposition with B0 inhomogeneity correction
Coombs, B. D., Szumowski, J., & Coshow, W. R. (1997) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910380606 · Cited by 141
31 P NMR studies in Duchenne muscular dystrophy: Age‐related metabolic changes
Younkin, D. P., Berman, P., Sladky, J., Chee, C., Bank, W., & Chance, B. (1987) · Neurology · doi:10.1212/wnl.37.1.165 · Cited by 136
Mercuri, E. M., Jungbluth, H., & Francesco Muntoni, A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000183947.01362.fe · Cited by 111
The Limb-Girdle Muscular Dystrophies
Wicklund, M., & Kissel, J. T. (2014) · Neurologic Clinics · doi:10.1016/j.ncl.2014.04.005 · Cited by 97
FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients
Walter, M. C., Petersen, J. A., Stucka, R., Fischer, D., Schröder, R., Vorgerd, M., Schroers, A., Schreiber, H., Hanemann, C. O., Knirsch, U., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.013953 · Cited by 89 · cited 1×
“A) in the fukutin-related protein gene (FKRP) [1,2].”
BackgroundSelf-citationBushby, K., & Beckmann, J. S. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00183-9 · Cited by 62
Self-citationLodi, R., Muntoni, F., Taylor, J., Kumar, S., Sewry, C. A., Blamire, A. M., Styles, P., & Taylor, D. J. (1997) · Neuromuscular Disorders · doi:10.1016/s0960-8966(97)00108-9 · Cited by 60
The limb-girdle muscular dystrophies: Genetic and phenotypic definition of a disputed entity
Wicklund, M., & Hilton‐Jones, D. (2003) · Neurology · doi:10.1212/wnl.60.8.1230 · Cited by 28
Cited by
Advanced Body Composition Assessment: From Body Mass Index to Body Composition Profiling
Borga, M., West, J., Bell, J. D., Harvey, N. C., Romu, T., Heymsfield, S. B., & Dahlqvist Leinhard, O. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000722 · Cited by 606
Morrow, J. M., Sinclair, C. D. J., Fischmann, A., Machado, P. M., Reilly, M. M., Yousry, T. A., Thornton, J. S., & Hanna, M. G. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00242-2 · Cited by 342
Self-citationCarlier, P. G., Marty, B., Scheidegger, O., Loureiro de Sousa, P., Baudin, P.-Y., Snezhko, E., & Vlodavets, D. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-160145 · Cited by 186
“Quantitative variables and indices derived from NMR imaging but also spectroscopy constitute the most serious imaging candidates as biomarkers or outcome measures in clinical trials focusing on muscle pathology.”
BackgroundSelf-citation
Metadata
- Authors
- Willis, T. A., Hollingsworth, K. G., Coombs, A., Sveen, M.-L., Andersen, S., Stojkovic, T., Eagle, M., Mayhew, A., de Sousa, P. L., Dewar, L., Morrow, J. M., Sinclair, C. D. J., Thornton, J. S., Bushby, K., Lochmüller, H., Hanna, M. G., Hogrel, J.-Y., Carlier, P. G., Vissing, J., & Straub, V.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-08-14
- Volume
- 8
- Issue
- 8
- Pages
- e70993
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2137339327
- Cited by
- 176
- References
- 22
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.